Jacqueline Corrigan-Curay, JD, MD, is director of the Office of Medical Policy (OMP) within the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration (FDA). She leads the development, coordination, and implementation of medical policy programs and strategic initiatives. She works collaboratively with other CDER program areas, FDA centers, and stakeholders on enhancing policies to improve drug development and regulatory review processes. Prior to joining FDA, Dr. Corrigan-Curay served as supervisory medical officer with the Immediate Office of the Director, National Heart, Lung, and Blood Institute at NIH, where she focused on developing policies and procedures to enhance the clinical trial enterprise. She also served as the director of the Office of Biotechnology Activities, Office of Science Policy at NIH, where she was executive secretary of the NIH Recombinant DNA Advisory Committee. She has held positions as an attending physician with the Veterans Affairs (VA) Medical Center, policy analyst with the Congressional Office of Technology Assessment, and is a practicing attorney in Washington, D.C. Dr. Corrigan-Curay earned a law degree from Harvard Law School, a medical degree from the University of Maryland School of Medicine, and a bachelor’s degree in history of science from Harvard/Radcliffe College in Cambridge, Mass. She completed her training in internal medicine at Georgetown University Medical Center, where she also served as a clinical assistant professor of medicine. She continues to practice internal medicine part-time at the Washington D.C. VA Medical Center.